Anteo Diagnostics Ltd has released a press release.
Appendix 4E Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- CEO Appointment
- AnteoX Performance Validated by Two Global Battery Companies
- Application for quotation of securities - ADO
- Updated COVID-19 RAT receives Regulatory Approval in Europe
- Quarterly Update and Appendix 4C
Later from AnteoTech
- FY22 Results Announcement
- European RAT Clinical Trial Halted to Refocus Initiatives
- Managing Director AGM Presentation
- AnteoTech receives $3.2m R&D Tax Incentive
- Response to ASX Query
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech